From: Treatment of benign bone lesions with an injectable biphasic bone substitute
Parameter | Patients (n = 18) |  |
---|---|---|
Median age at index surgery | 14 years (range 6–25) |  |
Median follow up time | 36.5 months (range 12–80) |  |
Median time to recurrence after index surgery | 9.5 months (range 4–51) |  |
Sex | Â | Â |
Male/Female | 13/5 | Â |
Localization | Â | Â |
Humerus | 13 | Â |
Femur | 4 | Â |
Tibia | 1 | Â |
Imaging | Â | Â |
Median cyst volume | 27ml (range 10–63) |  |
Soft tissue leakage | 6 | Â |
Tumor entities | Â | Â |
Unicameral bone cyst | 13 | Â |
Aneurysmal bone cyst | 2 | Â |
Non-ossifying fibroma | 2 | Â |
Secondary aneurysmal bone cyst | 1 | Â |
Recurrent lesion | 11 | Â |
Surgical procedure | Â | Â |
Percutaneous treatment | 11 | Â |
Curettage | 7 | Â |
Median amount BCBS delivered | 18ml (range 10–38) |  |